PBM rebate pass-throughs must be examined by antitrust regulators, Chopra says
The rebates pharmacy benefit managers receive raise questions and should be examined by antitrust regulators to determine what their overall impact is on pharmaceutical pricing, Democratic FTC Commissioner Rohit Chopra said...To view the full article, register now.
Already a subscriber? Click here to view full article